| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 1992 | Characterization of a cis element required for packaging and replication of the human hepatitis B virus. | Chiang, PW; Jeng, KS; Hu, CP; Chang, CM | Virology 186(2), 701-11 | | | |
| 2008 | Decreased expression of UK114 is related to the differentiation status of human hepatocellular carcinoma. | Chong, CL; Huang, SF; Hu, CP; Chen, YL; Chou, HY; Chau, GY; Shew, JY; Tsai, YL; Chen, CT; Chang, C; Chen, ML | Cancer Epidemiology Biomarkers & Prevention 17(3), 535-42 | | | |
| 1991 | Differential formation of disulfide linkages in the core antigen of extracellular and intracellular hepatitis B virus core particles. | Jeng, KS; Hu, CP; Chang, CM | Journal of virology 65(7), 3924-7 | | | |
| 2015 | Doxorubicin Activates Hepatitis B Virus Replication by Elevation of p21 (Waf1/Cip1) and C/EBPalpha Expression. | Chen, YF; Chong, CL; Wu, YC; Wang, YL; Tsai, KN; Kuo, TM; Hong, MH; Hu, CP; Chen, ML; Chou, YC; Chang, C | PloS one 10(6), e0131743 | | | |
| 2011 | Dynamics of HBV cccDNA expression and transcription in different cell growth phase. | Chong, CL; Chen, ML; Wu, YC; Tsai, KN; Huang, CC; Hu, CP; Jeng, KS; Chou, YC; Chang, C | Journal of biomedical science 18, 96 | | | |
| 2000 | Effects of genomic length on translocation of hepatitis B virus polymerase-linked oligomer. | Ho, TC; Jeng, KS; Hu, CP; Chang, C | Journal of virology 74(19), 9010-8 | | | |
| 2005 | Evaluation of transcriptional efficiency of hepatitis B virus covalently closed circular DNA by reverse transcription-PCR combined with the restriction enzyme digestion method. | Chou, YC; Jeng, KS; Chen, ML; Liu, HH; Liu, TL; Chen, YL; Liu, YC; Hu, CP; Chang, C | Journal of virology 79(3), 1813-23 | | | |
| 2009 | HBV replication is significantly reduced by IL-6. | Kuo, TM; Hu, CP; Chen, YL; Hong, MH; Jeng, KS; Liang, CC; Chen, ML; Chang, C | Journal of biomedical science 16, 41 | | | |
| 2000 | Identification and characterization of a structural protein of hepatitis B virus: a polymerase and surface fusion protein encoded by a spliced RNA. | Huang, HL; Jeng, KS; Hu, CP; Tsai, CH; Lo, SJ; Chang, C | Virology 275(2), 398-410 | | | |
| 2007 | Long-term inhibition of hepatitis B virus in transgenic mice by double-stranded adeno-associated virus 8-delivered short hairpin RNA. | Chen, CC; Ko, TM; Ma, HI; Wu, HL; Xiao, X; Li, J; Chang, CM; Wu, PY; Chen, CH; Han, JM; Yu, CP; Jeng, KS; Hu, CP; Tao, MH | Gene therapy 14(1), 11-9 | | | |
| 2013 | One single nucleotide difference alters the differential expression of spliced RNAs between HBV genotypes A and D. | Huang, CC; Kuo, TM; Yeh, CT; Hu, CP; Chen, YL; Tsai, YL; Chen, ML; Chou, YC; Chang, C | Virus research 174(1-2), 18-26 | | | |
| 1987 | Production of hepatitis B virus in vitro by transient expression of cloned HBV DNA in a hepatoma cell line. | Chang, CM; Jeng, KS; Hu, CP; Lo, SJ; Su, TS; Ting, LP; Chou, CK; Han, SH; Pfaff, E; Salfeld, J | The EMBO journal 6(3), 675-80 | | | |
| 2008 | The role of helioxanthin in inhibiting human hepatitis B viral replication and gene expression by interfering with the host transcriptional machinery of viral promoters. | Tseng, YP; Kuo, YH; Hu, CP; Jeng, KS; Janmanchi, D; Lin, CH; Chou, CK; Yeh, SF | Antiviral research 77(3), 206-14 | | | |
| 2012 | Transforming growth factor-beta1 suppresses hepatitis B virus replication by the reduction of hepatocyte nuclear factor-4alpha expression. | Hong, MH; Chou, YC; Wu, YC; Tsai, KN; Hu, CP; Jeng, KS; Chen, ML; Chang, C | PloS one 7(1), e30360 | | | |
| 2012 | Transforming growth factor-beta1 suppresses hepatitis B virus replication by the reduction of hepatocyte nuclear factor-4alpha expression. | Hong, MH; Chou, YC; Wu, YC; Tsai, KN; Hu, CP; Jeng, KS; Chen, ML; Chang, C | PloS one 7(1), e30360 | | | |
| 2007 | Transforming growth factor-beta1 suppresses hepatitis B virus replication primarily through transcriptional inhibition of pregenomic RNA. | Chou, YC; Chen, ML; Hu, CP; Chen, YL; Chong, CL; Tsai, YL; Liu, TL; Jeng, KS; Chang, C | Hepatology (Baltimore, Md.) 46(3), 672-81 | | | |
| 2012 | Use of RNA Interference to Modulate Liver Adenoma Development in A Murine Model Transgenic for Hepatitis B Virus | Chen, CC; Chang, CM; Sun, CP; Yu, CP; Wu, PY; Jeng, KS; Hu, CP; Chen, PJ; Wu, JC; Shih, CH; Gershwin, ME; Tao, MH. | GENE THERAPY 19(1), 25-33 | | | |
| 2012 | Use of RNA interference to modulate liver adenoma development in a murine model transgenic for hepatitis B virus. | Chen, CC; Chang, CM; Sun, CP; Yu, CP; Wu, PY; Jeng, KS; Hu, CP; Chen, PJ; Wu, JC; Shih, CH; Gershwin, ME; Tao, MH | Gene therapy 19(1), 25-33 | | | |
